{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:49:53Z","timestamp":1794091793373,"version":"4.8.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T00:00:00Z","timestamp":1673740800000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1620957"],"award-info":[{"award-number":["DMS-1620957"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1950254"],"award-info":[{"award-number":["DMS-1950254"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1951595"],"award-info":[{"award-number":["DMS-1951595"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jtbi.2022.111006","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T21:45:57Z","timestamp":1641591957000},"page":"111006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A two-sex model of human papillomavirus infection: Vaccination strategies and a case study"],"prefix":"10.1016","volume":"536","author":[{"given":"Shasha","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Martcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jtbi.2022.111006_b0005","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1002\/mma.7117","article-title":"Uncertainty and sensitivity of the sexual behavior changes to the current human papillomavirus vaccination campaign in spain","volume":"44","author":"Acedo","year":"2021","journal-title":"Math. Methods Appl. Sci."},{"key":"10.1016\/j.jtbi.2022.111006_b0010","doi-asserted-by":"crossref","unstructured":"Arie, S. HPV: WHO calls for countries to suspend vaccination of boys. Brit. Med. J. 367. https:\/\/www.bmj.com\/content\/367\/bmj.l6765.","DOI":"10.1136\/bmj.l6765"},{"key":"10.1016\/j.jtbi.2022.111006_b0015","unstructured":"Australian Government Department of Health, Human papillomavirus (HPV) immunisation service, https:\/\/www.health.gov.au\/health-topics\/immunisation\/immunisation-services\/human-papillomavirus-hpv-immunisation-service (2021)."},{"issue":"2","key":"10.1016\/j.jtbi.2022.111006_b0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5540\/tema.2019.020.02.305","article-title":"Assessing the impact of prophylactic vaccines on HPV prevalence","volume":"20","author":"Azevedo","year":"2019","journal-title":"TEMA (S\u00e3o Carlos)"},{"key":"10.1016\/j.jtbi.2022.111006_b0025","first-page":"61","article-title":"5. The potential public health impact of vaccines against human papillomavirus","author":"Barnabas","year":"2004","journal-title":"HPV Handbook"},{"issue":"5","key":"10.1016\/j.jtbi.2022.111006_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030138","article-title":"Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses","volume":"3","author":"Barnabas","year":"2006","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.epidem.2010.02.002","article-title":"HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions","volume":"2","author":"Baussano","year":"2010","journal-title":"Epidemics"},{"issue":"12","key":"10.1016\/j.jtbi.2022.111006_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001147","article-title":"Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models","volume":"8","author":"Bogaards","year":"2011","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.jtbi.2022.111006_b0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/jir285","article-title":"Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity","volume":"204","author":"Brisson","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0050","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2468-2667(16)30001-9","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","volume":"1","author":"Brisson","year":"2016","journal-title":"Lancet Public Health"},{"issue":"3","key":"10.1016\/j.jtbi.2022.111006_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151098","article-title":"Age effects and temporal trends in HPV-related and HPV-unrelated oral cancer in the United States: a multistage carcinogenesis modeling analysis","volume":"11","author":"Brouwer","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.jtbi.2022.111006_b0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/17486700903486613","article-title":"The HPV vaccination strategy: could male vaccination have a significant impact?","volume":"11","author":"Brown","year":"2010","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.jtbi.2022.111006_b0065","unstructured":"Centers for Disease Control and Prevention (CDC), Human Papillomavirus (HPV) Fact Sheet, https:\/\/www.cdc.gov\/std\/hpv\/stdfact-hpv.htm (2021)."},{"issue":"46","key":"10.1016\/j.jtbi.2022.111006_b0070","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05632-0","article-title":"Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study","volume":"21","author":"Cody","year":"2021","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12962-017-0080-9","article-title":"Cost-effectiveness of human papillomavirus vaccination in Germany","volume":"15","author":"Damm","year":"2017","journal-title":"Cost Effectiveness Resource Allocation"},{"key":"10.1016\/j.jtbi.2022.111006_b0085","first-page":"1","article-title":"Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States","author":"Daniels","year":"2021","journal-title":"Human Vaccines Immunother."},{"issue":"3","key":"10.1016\/j.jtbi.2022.111006_b0090","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/ijerph18030963","article-title":"Impact of a gender-neutral HPV vaccination program in men who have sex with men (MSM)","volume":"18","author":"D\u00edez-Domingo","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jtbi.2022.111006_b0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1090\/conm\/410\/07723","article-title":"Impact of prophylactic vaccination against human papillomavirus infection","volume":"410","author":"Elbasha","year":"2006","journal-title":"Contemporary Math."},{"issue":"3","key":"10.1016\/j.jtbi.2022.111006_b0100","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s11538-007-9283-0","article-title":"Global stability of equilibria in a two-sex HPV vaccination model","volume":"70","author":"Elbasha","year":"2008","journal-title":"Bull. Math. Biol."},{"issue":"42","key":"10.1016\/j.jtbi.2022.111006_b0105","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1016\/j.vaccine.2010.08.030","article-title":"Impact of vaccinating boys and men against HPV in the United States","volume":"28","author":"Elbasha","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jtbi.2022.111006_b0115","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1007\/s11538-008-9338-x","article-title":"A multi-type HPV transmission model","volume":"70","author":"Elbasha","year":"2008","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.jtbi.2022.111006_b0120","unstructured":"Fig. 1.9 Sex ratio at birth, 1982\u20132017, https:\/\/www.unicef.cn\/en\/figure-19-sex-ratio-birth-19822017 (2018)."},{"key":"10.1016\/j.jtbi.2022.111006_b0125","article-title":"The theory of matrices","volume":"131","author":"Gantmakher","year":"1959","journal-title":"Am. Math. Soc."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11538-020-00830-y","article-title":"A dynamic model to assess human papillomavirus vaccination strategies in a heterosexual population combined with men who have sex with men","volume":"83","author":"Gao","year":"2021","journal-title":"Bull. Math. Biol."},{"issue":"10145","key":"10.1016\/j.jtbi.2022.111006_b0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0140-6736(18)31728-8","article-title":"HPV vaccine to be offered to boys in England","volume":"392","author":"Green","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jtbi.2022.111006_b0140","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jval.2015.08.010","article-title":"Cost-effectiveness analysis of universal human papillomavirus vaccination using a dynamic Bayesian methodology: the BEST II study","volume":"18","author":"Haeussler","year":"2015","journal-title":"Value Health"},{"issue":"19","key":"10.1016\/j.jtbi.2022.111006_b0145","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.vaccine.2013.03.006","article-title":"Estimating the long-term effects of HPV vaccination in Germany","volume":"31","author":"Horn","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.vaccine.2007.10.056","article-title":"Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation","volume":"26","author":"Insinga","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jtbi.2022.111006_b0155","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jtbi.2022.111006_b0160","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.bjc.6604023","article-title":"The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting","volume":"97","author":"Kim","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jtbi.2022.111006_b0165","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7150\/jca.4161","article-title":"A mathematical model of human papillomavirus (HPV) in the United States and its impact on cervical cancer","volume":"3","author":"Lee","year":"2012","journal-title":"J. Cancer"},{"issue":"14","key":"10.1016\/j.jtbi.2022.111006_b0170","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2022.111006_b0175","unstructured":"Liuzhou statistical yearbook, http:\/\/lztj.liuzhou.gov.cn\/xxgk\/jcxxgk\/sjfb\/tjnj\/201811\/P020181113530838124483.pdf (2015)."},{"issue":"2","key":"10.1016\/j.jtbi.2022.111006_b0180","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.vaccine.2020.10.089","article-title":"Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France","volume":"39","author":"Majed","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jtbi.2022.111006_b0185","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3934\/dcdsb.2013.18.2151","article-title":"Qualitative analysis of an age-and sex-structured vaccination model for human papillomavirus","volume":"18","author":"Malik","year":"2013","journal-title":"Discrete Continuous Dyn. Syst.-B"},{"issue":"4","key":"10.1016\/j.jtbi.2022.111006_b0190","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3934\/mbe.2013.10.1173","article-title":"The impact of an imperfect vaccine and pap cytology screening on the transmission of human papillomavirus and occurrence of associated cervical dysplasia and cancer","volume":"10","author":"Malik","year":"2013","journal-title":"Math. Biosci. Eng."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","article-title":"A methodology for performing global uncertainty and sensitivity analysis in systems biology","volume":"254","author":"Marino","year":"2008","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2022.111006_b0200","volume":"vol. 61","author":"Martcheva","year":"2015"},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12962-017-0073-8","article-title":"Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy","volume":"15","author":"Mennini","year":"2017","journal-title":"Cost Effectiveness and Resource Allocation"},{"key":"10.1016\/j.jtbi.2022.111006_b0210","unstructured":"Mortality among children aged 5\u201314 years,https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mortality-among-children-aged-5-14-years (2019)."},{"issue":"5","key":"10.1016\/j.jtbi.2022.111006_b0215","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/v13050906","article-title":"On the elimination of infections related to oncogenic human papillomavirus: An approach using a computational network model","volume":"13","author":"Mu\u00f1oz-Quiles","year":"2021","journal-title":"Viruses"},{"issue":"07","key":"10.1016\/j.jtbi.2022.111006_b0220","doi-asserted-by":"crossref","first-page":"1850092","DOI":"10.1142\/S1793524518500924","article-title":"Mathematical analysis of a two-sex Human Papillomavirus (HPV) model","volume":"11","author":"Omame","year":"2018","journal-title":"Int. J. Biomath."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0225","first-page":"1","article-title":"Age-structured population modeling of HPV-related cervical cancer in Texas and US","volume":"8","author":"Peng","year":"2018","journal-title":"Scientific Rep."},{"issue":"11","key":"10.1016\/j.jtbi.2022.111006_b0230","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"Morb. Mortal. Wkly Rep."},{"issue":"51","key":"10.1016\/j.jtbi.2022.111006_b0235","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1073\/pnas.1714712114","article-title":"Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity","volume":"114","author":"Ranjeva","year":"2017","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jtbi.2022.111006_b0240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/imammb\/dqt001","article-title":"Deterministic modelling for transmission of Human Papillomavirus 6\/11: impact of vaccination","volume":"31","author":"Ribassin-Majed","year":"2014","journal-title":"Math. Med. Biol."},{"issue":"52","key":"10.1016\/j.jtbi.2022.111006_b0245","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1016\/j.vaccine.2017.10.103","article-title":"Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland","volume":"35","author":"Riesen","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jtbi.2022.111006_b0250","unstructured":"Salda\u00f1a, F., Camacho-Gut\u00ederrez, J.A., Barradas, I., Korobeinikov, A. When optimal is not the best: cost effectiveness analysis for HPV epidemic models, arXiv preprint arXiv:2011.06594."},{"key":"10.1016\/j.jtbi.2022.111006_b0255","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.apm.2017.03.025","article-title":"A model to assess the effect of vaccine compliance on Human Papillomavirus infection and cervical cancer","volume":"47","author":"Sharomi","year":"2017","journal-title":"Appl. Math. Model."},{"issue":"7413","key":"10.1016\/j.jtbi.2022.111006_b0260","doi-asserted-by":"crossref","DOI":"10.1038\/488S10a","article-title":"Perspective: vaccinate boys too","volume":"488","author":"Stanley","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2022.111006_b0265","unstructured":"Tabulation on the 2010 Population Census of China, http:\/\/www.stats.gov.cn\/tjsj\/pcsj\/rkpc\/6rp\/indexch.htm (2011)."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/875647939000600106","article-title":"Interpretation of the correlation coefficient: a basic review","volume":"6","author":"Taylor","year":"1990","journal-title":"J. Diagnost. Med. Sonogr."},{"issue":"21","key":"10.1016\/j.jtbi.2022.111006_b0275","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1158\/0008-5472.CAN-10-0621","article-title":"Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity","volume":"70","author":"Trottier","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jtbi.2022.111006_b0280","unstructured":"Under-five mortality rate (probability of dying by age 5 per 1000 live births), https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/under-five-mortality-rate-(probability-of-dying-by-age-5-per-1000-live-births) (2021)."},{"issue":"1\u20132","key":"10.1016\/j.jtbi.2022.111006_b0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-5564(02)00108-6","article-title":"Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission","volume":"180","author":"Van den Driessche","year":"2002","journal-title":"Math. Biosci."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2016.118","article-title":"Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study","volume":"5","author":"Wei","year":"2016","journal-title":"Emerging Microbes Infect."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0295","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/cid\/ciz168","article-title":"Sex differences in the incidence and clearance of anogenital human papillomavirus infection in Liuzhou, China: an observational cohort study","volume":"70","author":"Wei","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jtbi.2022.111006_b0300","unstructured":"WHO, HPV: News, https:\/\/www.who.int\/news-room\/detail\/31-10-2019-major-milestone-reached-as-100-countries-have-introduced-hpv-vaccine-into-national-schedule (2019)."},{"key":"10.1016\/j.jtbi.2022.111006_b0305","unstructured":"WHO, HPV: key facts, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papillomavirus-(hpv)-and-cervical-cancer (2021)."},{"issue":"4","key":"10.1016\/j.jtbi.2022.111006_b0310","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jinf.2017.01.007","article-title":"No evidence for cross-protection of the HPV-16\/18 vaccine against HPV-6\/11 positivity in female STI clinic visitors","volume":"74","author":"Woestenberg","year":"2017","journal-title":"J. Infect."},{"issue":"2","key":"10.1016\/j.jtbi.2022.111006_b0315","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jix582","article-title":"Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors","volume":"217","author":"Woestenberg","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jtbi.2022.111006_b0320","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.3934\/mbe.2020294","article-title":"Mathematical analysis of a human papillomavirus transmission model with vaccination and screening","volume":"17","author":"Zhang","year":"2020","journal-title":"Math. Biosci. Eng."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0325","first-page":"1","article-title":"An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas","volume":"11","author":"Zhong","year":"2021","journal-title":"Scientific Rep."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111006_b0330","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3934\/mbe.2017022","article-title":"A male-female mathematical model of human papillomavirus (HPV) in African American population","volume":"14","author":"Ziyadi","year":"2017","journal-title":"Math. Biosci. Eng."}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519322000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519322000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:32:57Z","timestamp":1758385977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519322000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":66,"alternative-id":["S0022519322000042"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2022.111006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.19.21268067","asserted-by":"object"}]},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A two-sex model of human papillomavirus infection: Vaccination strategies and a case study","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2022.111006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111006"}}